Search research articles
Contact Us
Filters
Showing results (1011-1020 of 1,047) with videos related to
Page
of 105
Sort By:
Evidence-Based Complementary and Alternative Medicine : Ecam
|
May 12, 2015
A survey of the practice and perspectives of chinese acupuncturists on deqi
Yu-Lan Ren, Tai-Pin Guo, Huai-Bin Du, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 3, 2021
Systemic Blockade of Clever-1 Elicits Lymphocyte Activation Alongside Checkpoint Molecule Downregulation in Patients with Solid Tumors: Results from a Phase I/II Clinical Trial
Reetta Virtakoivu, Jenna H Rannikko, Miro Viitala, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 11, 2025
Addition of dendritic cell vaccination to conditioning cyclophosphamide and chemoembolisation in patients with hepatocellular carcinoma: the ImmunoTACE trial
Yuk Ting Ma, Jianmin Zuo, Amanda Kirkham, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
June 5, 2025
Quantitative and Dynamic ctDNA as a Biomarker of Response and Survival in Patients With Advanced Lung Squamous Cell Carcinoma Receiving Immunochemotherapy or Chemotherapy Alone
Fei Zhou, Jiao Zhang, Shengxiang Ren, et al.
Cardiovascular and Interventional Radiology
|
February 28, 2023
Textbook Outcome After Trans-arterial Chemoembolization for Hepatocellular Carcinoma
Cristina Mosconi, Joanne O'Rourke, Roman Kloeckner, et al.
BMC Public Health
|
September 24, 2025
Sex and age-specific multimorbidity profiles among working-age inpatients in China: a comparative network analysis
Yining Bao, Yang Sun, Mengjie Wang, et al.
European Journal of Medicinal Chemistry
|
May 21, 2025
Discovery of quinazoline derivatives as RIPK3 inhibitors that switch cell death from necroptosis to apoptosis for psoriasis treatment
Ya-Ling Hong, Zheng-Xing Wu, Jia-Xing Jiang, et al.
Cell Reports. Medicine
|
December 6, 2023
Bexmarilimab-induced macrophage activation leads to treatment benefit in solid tumors: The phase I/II first-in-human MATINS trial
Jenna H Rannikko, Loic Verlingue, Maria de Miguel, et al.
The Lancet. Oncology
|
April 2, 2021
Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial
Angela Lamarca, Daniel H Palmer, Harpreet Singh Wasan, et al.
ACS Pharmacology & Translational Science
|
July 17, 2025
Targeting of a Bile Acid Receptor, Takeda G Protein Receptor 5 [TGR5], by a Novel First-in-Class Competitive Antagonist, SBI-364, Diminishes Hepatic and Renal Cystogenesis in Polycystic Liver and Kidney Disease
Tetyana Masyuk, Anatoliy Masyuk, Christy Trussoni, et al.
Page
of 105
Search research articles
Search
Showing results (1011-1020 of 1,047) with videos related to
Sort By:
Page
of 105
Evidence-Based Complementary and Alternative Medicine : Ecam
|
May 12, 2015
A survey of the practice and perspectives of chinese acupuncturists on deqi
Yu-Lan Ren, Tai-Pin Guo, Huai-Bin Du, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 3, 2021
Systemic Blockade of Clever-1 Elicits Lymphocyte Activation Alongside Checkpoint Molecule Downregulation in Patients with Solid Tumors: Results from a Phase I/II Clinical Trial
Reetta Virtakoivu, Jenna H Rannikko, Miro Viitala, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 11, 2025
Addition of dendritic cell vaccination to conditioning cyclophosphamide and chemoembolisation in patients with hepatocellular carcinoma: the ImmunoTACE trial
Yuk Ting Ma, Jianmin Zuo, Amanda Kirkham, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
June 5, 2025
Quantitative and Dynamic ctDNA as a Biomarker of Response and Survival in Patients With Advanced Lung Squamous Cell Carcinoma Receiving Immunochemotherapy or Chemotherapy Alone
Fei Zhou, Jiao Zhang, Shengxiang Ren, et al.
Cardiovascular and Interventional Radiology
|
February 28, 2023
Textbook Outcome After Trans-arterial Chemoembolization for Hepatocellular Carcinoma
Cristina Mosconi, Joanne O'Rourke, Roman Kloeckner, et al.
BMC Public Health
|
September 24, 2025
Sex and age-specific multimorbidity profiles among working-age inpatients in China: a comparative network analysis
Yining Bao, Yang Sun, Mengjie Wang, et al.
European Journal of Medicinal Chemistry
|
May 21, 2025
Discovery of quinazoline derivatives as RIPK3 inhibitors that switch cell death from necroptosis to apoptosis for psoriasis treatment
Ya-Ling Hong, Zheng-Xing Wu, Jia-Xing Jiang, et al.
Cell Reports. Medicine
|
December 6, 2023
Bexmarilimab-induced macrophage activation leads to treatment benefit in solid tumors: The phase I/II first-in-human MATINS trial
Jenna H Rannikko, Loic Verlingue, Maria de Miguel, et al.
The Lancet. Oncology
|
April 2, 2021
Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial
Angela Lamarca, Daniel H Palmer, Harpreet Singh Wasan, et al.
ACS Pharmacology & Translational Science
|
July 17, 2025
Targeting of a Bile Acid Receptor, Takeda G Protein Receptor 5 [TGR5], by a Novel First-in-Class Competitive Antagonist, SBI-364, Diminishes Hepatic and Renal Cystogenesis in Polycystic Liver and Kidney Disease
Tetyana Masyuk, Anatoliy Masyuk, Christy Trussoni, et al.
Page
of 105